Aesica Pharmaceuticals Limited
Overview
Aesica Pharmaceuticals Limited is a leading contract development and manufacturing organization (CDMO) that provides extensive pharmaceutical services ranging from drug development to finished product manufacturing. It is a subsidiary of Recipharm AB, a global CDMO headquartered in Sweden.
Therapeutic areas
API / Drug Master Files
Aesica Pharmaceuticals Limited holds 0 active (2 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- PAROXETINE HYDROCHLORIDE HEMIHYDRATEInactive2011-05-05
- PAROXETINE HYDROCHLORIDEInactive2000-06-01
FDA compliance signals
2 FDA enforcement records linked to this company.
- 4832014-06-20
Investigations of discrepancies, failures
- 4832014-06-20
Absence of Written Procedures
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.